Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),General Medicine
Reference30 articles.
1. Cowan AJ, Green DJ, Kwok M, et al. Diagnosis and management of multiple myeloma: a review. JAMA. 2022;327(5):464–77. https://doi.org/10.1001/jama.2022.0003. (PMID: 35103762).
2. Moreau P, San Miguel J, Sonneveld P, et al. Multiple myeloma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2017;28(4):52–61. https://doi.org/10.1093/annonc/mdx096. (PMID: 28453614).
3. Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209–49. https://doi.org/10.3322/caac.21660.
4. National Cancer Institute: Surveillance Epidemiology and End Results Program. Cancer Statistics Explorer Network; Apr 19, 2023. [updated Jun 8, 2023]. https://seer.cancer.gov/statistics-network/explorer/application.html?site=89&data_type=9&graph_type=2&compareBy=rate_type&chk_rate_type_1=1&chk_rate_type_2=2&chk_rate_type_3=3&sex=1&race=1&age_range=1&hdn_stage=101&advopt_precision=1&advopt_show_ci=on&hdn_view=0&advopt_show_apc=on&advopt_display=2#resultsRegion0. Accessed June 16, 2023.
5. Lee HC, Ramasamy K, Weisel K, et al. Treatment patterns, survival, quality of life, and healthcare resource use among patients with triple-class refractory multiple myeloma in US clinical practice: findings from the connect MM disease registry. Clin Lymphoma Myeloma Leuk. 2023;23(2):112–22. https://doi.org/10.1016/j.clml.2022.11.008. (PMID: 36567211).